Literature DB >> 9531822

[Clostridium difficile-associated diarrhea treated with homologous feces].

S Lund-Tønnesen1, A Berstad, A Schreiner, T Midtvedt.   

Abstract

The incidence of Clostridium difficile-associated diarrhoea has increased during the last few years. Treatment with vankomycin or metronidazol is usually effective, but relapses are not uncommon. Some good results have been reported with faecal enemas, but it is a controversal form of treatment. 18 patients with C. difficile-associated diarrhoea were given homologous faeces from one healthy donor. In 17 patients faeces was instillated via a coloscope and in one patient via a gastrostoma. C. difficile toxin was detected in all patients. Three patients with severe colitis did not respond to the treatment. The remaining patients were clinically cured, and no relapses were observed. Treatment of C. difficile-associated diarrhoea with faeces appears to be an alternative in moderate cases. In our limited number of patients we observed a poor correlation between the clinical picture, the endoscopic findings and the histological findings in colon biopsies. The ethical aspects of treatment with faeces will continue to be subject to discussion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531822

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  16 in total

Review 1.  Recurrent Clostridium difficile infection: what are the treatment options?

Authors:  Claire M F van Nispen tot Pannerden; Annelies Verbon; Ernst J Kuipers
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

2.  Intestinal microbiota and the efficacy of fecal microbiota transplantation in gastrointestinal disease.

Authors:  Olga C Aroniadis; Lawrence J Brandt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-04

Review 3.  Restoring the gut microbiome for the treatment of inflammatory bowel diseases.

Authors:  Jessica R Allegretti; Matthew J Hamilton
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 4.  Clostridium difficile infection: guideline-based diagnosis and treatment.

Authors:  Christoph Lübbert; Endres John; Lutz von Müller
Journal:  Dtsch Arztebl Int       Date:  2014-10-24       Impact factor: 5.594

Review 5.  Scaling Safe Access to Fecal Microbiota Transplantation: Past, Present, and Future.

Authors:  Ryan Eliott; Pratik Panchal; Shrish Budree; Alex Scheeler; Geraldine Medina; Monica Seng; Wing Fei Wong; Thomas Mitchell; Zain Kassam; Jessica R Allegretti; Majdi Osman
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 6.  Fecal microbiota transplantation and emerging applications.

Authors:  Thomas J Borody; Alexander Khoruts
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-20       Impact factor: 46.802

Review 7.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

8.  Fecal microbiota transplantation in relapsing Clostridium difficile infection.

Authors:  Faith Rohlke; Neil Stollman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

9.  Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis.

Authors:  Woo Jung Lee; Lakshmi D N Lattimer; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-01

Review 10.  Fecal microbiota transplantation for management of Clostridium difficile infection.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2014-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.